US Patent 7135471 Aryl oximes
All edits
Edits on 2 Mar, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Hans-Michael Eggenweiler0
Michael Wolf0
Norbert Beier0
Pierre Schelling0
Edits on 31 Aug, 2023
Golden AI
Edits made to:
Article (+397 characters)
Article
Patent abstract
Aryl oxime derivatives of the formula (I), in which R1, R2, R3, X and B are as defined in claim 1, act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07135471 Aryl oximes US Patent 7135471 Aryl oximes
Infobox
Patent Number
071354710
Patent Number
71354710
Edits on 22 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
071354710
Date of Patent
November 14, 2006
0Patent Application Number
105174380
Date Filed
May 16, 2003
0Official Website
Patent Primary Examiner
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 19 Nov, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07135471 Aryl oximes
Infobox
Is a
Patent jurisdiction
Patent number
07135471
Date of patent
November 14, 2006
Patent application number
10517438
Date Filed
May 16, 2003
Patent primary examiner
Find more entities like US Patent 7135471 Aryl oximes
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
